Treace Medical Concepts, Inc.
TMCI
$1.24
-$0.07-5.34%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.01% | 11.37% | 6.60% | 2.86% | 10.44% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.01% | 11.37% | 6.60% | 2.86% | 10.44% |
| Cost of Revenue | -8.41% | 17.36% | 9.73% | 5.43% | 15.36% |
| Gross Profit | -9.15% | 9.89% | 5.82% | 2.23% | 9.33% |
| SG&A Expenses | 2.60% | 7.34% | -5.15% | -5.08% | -5.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.68% | 7.75% | -2.24% | -2.75% | -0.12% |
| Operating Income | -2,802.94% | 3.03% | 20.62% | 17.85% | 96.99% |
| Income Before Tax | -1,775.05% | -6.04% | 17.96% | 14.75% | 92.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1,775.05% | -6.04% | 17.96% | 14.75% | 92.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1,775.05% | -6.04% | 17.96% | 14.75% | 92.02% |
| EBIT | -2,802.94% | 3.03% | 20.62% | 17.85% | 96.99% |
| EBITDA | -498.26% | 8.31% | 25.27% | 23.08% | 118.74% |
| EPS Basic | -1,738.75% | -3.89% | 19.17% | 15.92% | 92.14% |
| Normalized Basic EPS | -1,204.00% | 2.53% | 19.16% | 15.93% | 92.14% |
| EPS Diluted | -1,287.74% | -3.89% | 19.17% | 15.92% | 89.59% |
| Normalized Diluted EPS | -1,204.00% | 2.53% | 19.16% | 15.93% | 92.14% |
| Average Basic Shares Outstanding | 2.44% | 2.07% | 1.49% | 1.41% | 1.04% |
| Average Diluted Shares Outstanding | 2.44% | 2.07% | 1.49% | 1.41% | 1.04% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |